Select Publications
Books
2012, Foreword, http://dx.doi.org/10.1142/9789814343602_fmatter
,Book Chapters
2024, 'Epidemiology, Microbiome, and Risk Factors Involved in Carcinogenesis of Esophagus, Gastric, and Intestine', in , Wiley, pp. 2 - 22, http://dx.doi.org/10.1002/9781119756422.ch1
,2024, 'Epidemiology, Microbiome, and Risk Factors Involved in Carcinogenesis of Esophagus, Gastric, and Intestine', in Jankowski JAZ (ed.), Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach, Wiley, pp. 3 - 22, http://dx.doi.org/10.1002/9781119756422.ch1
,2024, 'Screening, Surveillance, and Prevention of Esophageal and Gastric Cancers', in Jankowski JAZ (ed.), Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach, Wiley, pp. 42 - 62, http://dx.doi.org/10.1002/9781119756422.ch3
,2022, 'Tumors of the stomach', in , Wiley, pp. 1023 - 1046, http://dx.doi.org/10.1002/9781119600206.ch52
,2022, 'Tumors of the stomach', in Yamada's Atlas of Gastroenterology: Sixth Edition, pp. 170 - 176, http://dx.doi.org/10.1002/9781119600527.ch19
,2022, 'Participants aux Davidson's Principles and Practice of Medicine, 23eédition', in Davidson : L'essentiel de la Médecine, Elsevier, pp. ix - xiv, http://dx.doi.org/10.1016/b978-2-294-77556-7.09990-2
,2019, 'Helicobacter pylori, peptic ulcer disease and gastric cancer', in Eslick G (ed.), Gastrointestinal Diseases and Their Associated Infections, Elsevier, St Louis, pp. 17 - 29, http://dx.doi.org/10.1016/b978-0-323-54843-4.00002-7
,2019, 'Connective Tissue Disorders, Gastrointestinal Tract Manifestations of', in Encyclopedia of Gastroenterology, Second Edition, pp. 727 - 733, http://dx.doi.org/10.1016/B978-0-12-801238-3.65658-1
,2019, 'Epithelial Barrier Function', in Encyclopedia of Gastroenterology, Second Edition, pp. 300 - 313, http://dx.doi.org/10.1016/B978-0-12-801238-3.65657-X
,2019, 'Vasculitis, Gastrointestinal Manifestations of', in Encyclopedia of Gastroenterology, Second Edition, pp. 700 - 706, http://dx.doi.org/10.1016/B978-0-12-801238-3.65670-2
,2019, 'Chapter 2 Helicobacter pylori, Peptic Ulcer Disease and Gastric Cancer', in Gastrointestinal Diseases and their Associated Infections, Elsevier, pp. 17 - 29, http://dx.doi.org/10.1016/b978-0-323-54843-4.00002-7
,2016, 'Tumors of the stomach', in Podolsky DK; Camilleri M; Fitz JG; Kalloo AN; Shanahan F; Wang TC (ed.), Yamada's Atlas of Gastroenterology, John Wiley & Sons, pp. 149 - 152
,2016, 'Influence of host gene polymorphisms on development of gastroduodenal diseases', in Helicobacter pylori Research: From Bench to Bedside, pp. 339 - 362, http://dx.doi.org/10.1007/978-4-431-55936-8_14
,2015, 'Tumors of the Stomach', in , Wiley, pp. 1121 - 1140, http://dx.doi.org/10.1002/9781118512074.ch59
,2009, 'Role of host genetic susceptibility in the pathogenesis of gastric cancer', in The Biology of Gastric Cancers, pp. 235 - 250, http://dx.doi.org/10.1007/978-0-387-69182-4_9
,2003, 'Gastric Cancer in the Elderly', in Interdisciplinary Topics in Gerontology, KARGER, pp. 145 - 156, http://dx.doi.org/10.1159/000072618
,1996, 'Helicobacter pylori gastritis and gastric acid secretory function — an integrated approach', in Helicobacter pylori, Springer Netherlands, pp. 122 - 131, http://dx.doi.org/10.1007/978-94-009-1792-7_12
,1994, 'Effect of H. pylori infection on gastrin and gastric acid secretion', in Helicobacter pylori, Springer Netherlands, pp. 245 - 256, http://dx.doi.org/10.1007/978-94-011-1418-9_21
,'Analysis of Single Nucleotide Polymorphisms in the Interleukin-1B Gene Using 5' Nuclease Assays', in Interleukin Protocols, Humana Press, pp. 409 - 417, http://dx.doi.org/10.1385/1-59259-146-9:409
,Journal articles
2024, 'The Critical Role of Host and Bacterial Extracellular Vesicles in Endometriosis.', Biomedicines, 12, http://dx.doi.org/10.3390/biomedicines12112585
,2024, 'What defines a healthy gut microbiome?', Gut, 73, pp. 1893 - 1908, http://dx.doi.org/10.1136/gutjnl-2024-333378
,2024, 'The circulating methylome in childhood-onset inflammatory bowel disease.', J Crohns Colitis, http://dx.doi.org/10.1093/ecco-jcc/jjae157
,2024, 'The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines', Gut, 73, pp. 1607 - 1617, http://dx.doi.org/10.1136/gutjnl-2024-333029
,2024, 'β-resorcylic acid released by Limosilactobacillus reuteri protects against cisplatin-induced ovarian toxicity and infertility', Cell Reports Medicine, 5, http://dx.doi.org/10.1016/j.xcrm.2024.101678
,2024, 'Cannabidiol (CBD) facilitates cocaine extinction and ameliorates cocaine-induced changes to the gut microbiome in male C57BL/6JArc mice', Progress in Neuro-Psychopharmacology and Biological Psychiatry, 133, http://dx.doi.org/10.1016/j.pnpbp.2024.111014
,2024, '40 years after the discovery of Helicobacter pylori: towards elimination of H pylori for gastric cancer prevention', The Lancet, 403, pp. 2570 - 2572, http://dx.doi.org/10.1016/S0140-6736(24)01171-1
,2024, 'Recent advances in translating gut microbiota research into clinical practice at 12th Asian Pacific Topic Conference 2023', Journal of Gastroenterology and Hepatology (Australia), 39, pp. 979 - 981, http://dx.doi.org/10.1111/jgh.16565
,2024, 'Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022', Gastroenterology, 166, pp. 605 - 619, http://dx.doi.org/10.1053/j.gastro.2023.12.022
,2024, 'RE.GA.IN.: the Real-world Gastritis Initiative-updating the updates', Gut, 73, pp. 407 - 441, http://dx.doi.org/10.1136/gutjnl-2023-331164
,2024, 'Change in microbiota profile after vaginal estriol cream in postmenopausal women with stress incontinence', Frontiers in Microbiology, 15, http://dx.doi.org/10.3389/fmicb.2024.1302819
,2024, 'Oral, Vaginal, and Stool Microbial Signatures in Patients With Endometriosis as Potential Diagnostic Non-Invasive Biomarkers: A Prospective Cohort Study', BJOG: An International Journal of Obstetrics and Gynaecology, http://dx.doi.org/10.1111/1471-0528.17979
,2024, 'Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis', The Lancet Gastroenterology and Hepatology, 9, pp. 56 - 67, http://dx.doi.org/10.1016/S2468-1253(23)00281-9
,2024, 'Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease', Seminars in Liver Disease, http://dx.doi.org/10.1055/a-2438-4383
,2024, 'A Healthy Optimal Australian Microbiome sub-study: oral and gut microbiome dysbiosis in obesity is associated with reduced beneficial taxa', Obesity Research & Clinical Practice, 18, pp. S7 - S7, http://dx.doi.org/10.1016/j.orcp.2024.09.017
,2023, 'Helicobacter pylori infection', Nature Reviews Disease Primers, 9, http://dx.doi.org/10.1038/s41572-023-00431-8
,2023, 'Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis', BMC Medicine, 21, http://dx.doi.org/10.1186/s12916-023-02975-8
,2023, 'World Gastroenterology Organisation - Gut commentary series on digestive health and climate change', Gut, 72, pp. 2193 - 2196, http://dx.doi.org/10.1136/gutjnl-2023-331193
,2023, 'A Novel Bifidobacterium/Klebsiella Ratio in Characterization Analysis of the Gut and Bile Microbiota of CCA Patients', Microbial Ecology, 87, http://dx.doi.org/10.1007/s00248-023-02318-3
,2023, 'The MothersBabies Study, an Australian Prospective Cohort Study Analyzing the Microbiome in the Preconception and Perinatal Period to Determine Risk of Adverse Pregnancy, Postpartum, and Child-Related Health Outcomes: Study Protocol', International Journal of Environmental Research and Public Health, 20, pp. 6736, http://dx.doi.org/10.3390/ijerph20186736
,2023, 'Future directions in the microbiome field: an editor’s perspective', eGastroenterology, 1, http://dx.doi.org/10.1136/egastro-2023-100003
,2023, 'Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials', The Lancet Gastroenterology and Hepatology, 8, pp. 623 - 634, http://dx.doi.org/10.1016/S2468-1253(23)00097-3
,2023, 'Ten reasons gastroenterologists and hepatologists should be treating obesity', Gut, 72, pp. 1033 - 1038, http://dx.doi.org/10.1136/gutjnl-2023-329639
,2023, 'Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial', The Lancet Gastroenterology and Hepatology, 8, pp. 228 - 241, http://dx.doi.org/10.1016/S2468-1253(22)00384-3
,2023, 'Relationship between Diet Quality and Maternal Stool Microbiota in the MUMS Australian Pregnancy Cohort', Nutrients, 15, pp. 689, http://dx.doi.org/10.3390/nu15030689
,2023, 'Critical Assessment of Whole Genome and Viral Enrichment Shotgun Metagenome on the Characterization of Stool Total Virome in Hepatocellular Carcinoma Patients', Viruses, 15, pp. 53, http://dx.doi.org/10.3390/v15010053
,2023, '1683TiP Trial in progress: NEO-adjuvant chemo-IMmunotherapy in PAnCreaTic cancer-NEO-IMPACT', Annals of Oncology, 34, pp. S922 - S922, http://dx.doi.org/10.1016/j.annonc.2023.09.2630
,2023, '267 GENOTYPIC RESISTANCE GUIDED THERAPY VERSUS SUSCEPTIBILITY TESTING GUIDED THERAPY IN THE FIRST-LINE AND THIRD-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION-TWO MULTICENTER RANDOMIZED CONTROLLED TRIALS', Gastroenterology, 164, http://dx.doi.org/10.1016/s0016-5085(23)01068-5
,2022, 'A Tale of Two Fibers: A Liver Twist!', Gastroenterology, 163, pp. 1495 - 1497, http://dx.doi.org/10.1053/j.gastro.2022.09.012
,2022, 'Dysbiosis in Head and Neck Cancer: Determining Optimal Sampling Site for Oral Microbiome Collection', Pathogens, 11, http://dx.doi.org/10.3390/pathogens11121550
,